Christian A. Garcia

September 25, 2026

Stifel Lowers TTI Target to $12 Amid Low‑Priced Stock List. Stifel keeps a positive view on TTI but cut its price target to $12, reflecting a more cautious outlook. The company is listed among stocks under $10 that some analysts avoid, and its price is near the lower end of its 52‑week range. Technical signals show a low RSI and a support level at $8.27, while revenue‑price divergence suggests a potential mismatch between earnings and stock price.

October 12, 2026

BHC appoints interim CEO and looks to raise FY26 EBITDA guidance. Bausch Health announced that its chairman, Thomas J. Appio, will serve as interim chief executive effective immediately. The company and its parent also said they expect to raise the adjusted EBITDA guidance for fiscal year 2026, not including the recently acquired IPR&D business. A separate notice confirms that the firm will release its third‑quarter 2026 results on October 28. Analysts at Zacks included Bausch Health in a recent coverage roundup, highlighting the stock among other health‑care names.

October 10, 2026

Goldman Sachs Lowers Mueller Water Products Target to $24. Goldman Sachs has kept a neutral stance on Mueller Water Products but cut its price target to $24. Other analysts highlighted the company as a cash‑producing stock and noted its solid interest coverage, which may appeal to traders seeking stable earnings. The new target is below the current trading level and near the 20‑touch support at $24.90. These updates could influence how traders view the stock’s valuation.